News Headline Summary

Synergy Pharmaceuticals (SYGP) price target raised to USD 13 from USD 7 at Cantor Fitzgerald

Update details:

- Earlier today, the Co. announced their drug Plecanatide met the primary and secondary endpoints of a Phase IIb/III clinical study, hence company shares seen trading up over 14% last.

Reaction details:

- Co. shares are unmoved in reaction to the news; trades USD 6.00 (+14.07%) last.

Print 17:37, 02 Jan 2013 - US Equities - Source: Newswires